Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
25.46
-0.04 (-0.16%)
At close: Mar 28, 2025, 4:00 PM
24.79
-0.68 (-2.65%)
Pre-market: Mar 31, 2025, 8:27 AM EDT
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $1.68 billion as of March 31, 2025. Its market cap has decreased by -26.36% in one year.
Market Cap
1.68B
Enterprise Value
-1.69B
1-Year Change
-26.36%
Ranking
Category
Stock Price
$25.46
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has decreased from $1.86B to $1.68B, a decrease of -9.97%. That is a compound annual growth rate of -1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.68B | -7.42% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.96B |
| UnitedHealth Group | 474.82B |
| Johnson & Johnson | 395.75B |
| AbbVie | 358.18B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.96B |
| Merck & Co. | 225.88B |
| AstraZeneca | 225.00B |